earnings
confidence high
sentiment negative
materiality 0.65
Integer Q3 sales up 12% to $343M; GAAP net income down 27% to $16M
Integer Holdings Corp
2022-Q3 EPS reported
$1.45
revenue$1,003,673,000
- Sales increased 12% to $343M; GAAP EPS $0.48 vs $0.66 prior year; adjusted EPS $0.95 vs $1.05.
- Cardio & Vascular sales +14%; Cardiac Rhythm Management +8%; Advanced Surgical +17%; Electrochem +24%.
- 2022 outlook: GAAP sales $1.35-1.38B, adj. EBITDA $244-260M, adj. EPS $3.57-3.97; organic growth 4-6%.
- Total debt rose $111M to $939M due to Aran Biomedical acquisition for $129M; leverage ratio 3.8x.
- CEO expects 2023 revenue growth of 7-9% with margin expansion; supply chain delays to be recovered in 2023.